Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC5A7 | Q9GZV3 | 8/20 | 0.33 |
| ▸ | PDE4D | Q08499 | 3/20 | 0.33 |
| ▸ | PDE4A | P27815 | 2/20 | 0.33 |
| ▸ | PDE4B | Q07343 | 2/20 | 0.33 |
| ▸ | PDE4C | Q08493 | 2/20 | 0.33 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | NAMPT | P43490 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25113812 | 0.87 | SLC5A7 (0.32) | SLC5A7PDE4DPDE4APDE4BPDE4C | |
| SCHEMBL25113809 | 0.87 | SLC5A7 (0.32) | SLC5A7PDE4DPDE4APDE4BPDE4C | |
| SCHEMBL23196124 | 0.86 | NAMPT (0.33) | SLC5A7NAMPT | |
| SCHEMBL23196125 | 0.85 | SLC5A7 (0.32) | SLC5A7EPHX2NAMPT | |
| SCHEMBL23195595 | 0.85 | GABRA5 (0.31) | SLC5A7 | |
| SCHEMBL23195997 | 0.83 | AR (0.31) | SLC5A7 | |
| SCHEMBL23196136 | 0.83 | UGCG (0.31) | SLC5A7 | |
| SCHEMBL23196269 | 0.83 | UGCG (0.31) | SLC5A7 | |
| SCHEMBL24987082 | 0.83 | ALDH1A1 (0.36) | PDE4DPDE4APDE4BPDE4C | |
| SCHEMBL25113808 | 0.83 | PDE4A (0.34) | SLC5A7PDE4DPDE4APDE4BPDE4C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023200441-A1 | ANTIVIRAL HETEROCYCLIC COMPOUNDS | ENANTA PHARMACEUTICALS, INC. (US) | 2023-10-19 | — | — | WO | disclosed |